Literature DB >> 19811499

Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappaB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteoblast-like cells.

Tisheeka R Graham1, Krishna C Agrawal, Asim B Abdel-Mageed.   

Abstract

The molecular mechanisms involved in prostate cancer (PC) metastasis and bone remodeling are poorly understood. We recently reported that phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) mediates transcriptional regulation and activation of bone morphogenetic protein (BMP)-2 signaling by nuclear factor (NF)-kappaB in bone metastatic prostate cancer cells. In the present study, we demonstrate that NF-kappaB, whether activated by recombinant human tumor necrosis factor (TNF)-alpha or by ectopic expression of the p65 subunit, is involved in extracellular matrix adhesion and invasion of osteotropic PC-3 and C4-2B, but not LNCaP, cells. The enhanced metastatic potential was associated with transcriptional upregulation of osteopontin, osteocalcin, and collagen IA1 in osteotropic PC cells, suggesting their role in osteomimicry of PC cells. Unlike BMP-4, BMP-2 protein enhanced the invasive properties of C4-2B cells, but not in LNCaP cells. Also, this effect was nullified by Noggin. In addition, BMP-2 mediates TNF-alpha-induced invasion of C4-2B cells in a NF-kappaB-dependent fashion. TNF-alpha or conditioned media (CM) of TNF-alpha-stimulated C4-2B cells upregulated BMP-2 and BMP-dependent Smad transcripts and inhibited receptor activator of NF-kappaB ligand transcripts in RAW 264.7 preosteoclast cells, respectively, implying that this factor may contribute to suppression of osteoclastogenesis via direct and paracrine mechanisms. In contrast, CM of TNF-alpha-stimulate or BMP2-stimulated C4-2B cells induced in vitro mineralization of MC3T3-E1 osteoblast cells in a BMP-2-dependent and NF-kappaB-dependent manner, respectively. Taken together, the results suggest that mutual interactions between these factors may be pivotal not only in enhancing the osteomimicry and metastatic potential of PC cells, but also in bone remodeling and in shifting the balance from osteoclastogenesis towards osteoblastogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811499      PMCID: PMC3092127          DOI: 10.1111/j.1349-7006.2009.01356.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  71 in total

Review 1.  Two major Smad pathways in TGF-beta superfamily signalling.

Authors:  Keiji Miyazawa; Masahiko Shinozaki; Takane Hara; Toshio Furuya; Kohei Miyazono
Journal:  Genes Cells       Date:  2002-12       Impact factor: 1.891

Review 2.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

3.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

Review 4.  TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity.

Authors:  E R Barrack
Journal:  Prostate       Date:  1997-04-01       Impact factor: 4.104

5.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

6.  Osteopontin: possible role in prostate cancer progression.

Authors:  G N Thalmann; R A Sikes; R E Devoll; J A Kiefer; R Markwalder; I Klima; C M Farach-Carson; U E Studer; L W Chung
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

7.  Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.

Authors:  Brian T Feeley; Lucie Krenek; Nancy Liu; Wellington K Hsu; Seth C Gamradt; Edward M Schwarz; Johnny Huard; Jay R Lieberman
Journal:  Bone       Date:  2005-08-26       Impact factor: 4.398

Review 8.  Osteopontin: role in cell signaling and cancer progression.

Authors:  Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Journal:  Trends Cell Biol       Date:  2006-01-10       Impact factor: 20.808

9.  Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.

Authors:  L C Hofbauer; C R Dunstan; T C Spelsberg; B L Riggs; S Khosla
Journal:  Biochem Biophys Res Commun       Date:  1998-09-29       Impact factor: 3.575

Review 10.  Osteoblastic metastasis in advanced prostate cancer.

Authors:  M Koutsilieris
Journal:  Anticancer Res       Date:  1993 Mar-Apr       Impact factor: 2.480

View more
  16 in total

1.  Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals.

Authors:  Laura L Hernandez; Karen A Gregerson; Nelson D Horseman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

Review 2.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

3.  PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer.

Authors:  Yinhui Yang; Yang Bai; Yundong He; Yu Zhao; Jiaxiang Chen; Linlin Ma; Yunqian Pan; Michael Hinten; Jun Zhang; R Jeffrey Karnes; Manish Kohli; Jennifer J Westendorf; Benyi Li; Runzhi Zhu; Haojie Huang; Wanhai Xu
Journal:  Clin Cancer Res       Date:  2017-11-22       Impact factor: 12.531

4.  Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.

Authors:  Said M Elshafae; Wessel P Dirksen; Aylin Alasonyalilar-Demirer; Justin Breitbach; Shiyu Yuan; Noriko Kantake; Wachiraphan Supsavhad; Bardes B Hassan; Zayed Attia; Lucas B Alstadt; Thomas J Rosol
Journal:  Prostate       Date:  2020-04-29       Impact factor: 4.104

Review 5.  RANK-mediated signaling network and cancer metastasis.

Authors:  Gina Chia-Yi Chu; Leland W K Chung
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

6.  Insights into bone health in Duchenne muscular dystrophy.

Authors:  Victor H Morgenroth; Lauren P Hache; Paula R Clemens
Journal:  Bonekey Rep       Date:  2012-02-01

7.  Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes.

Authors:  Zakaria Y Abd Elmageed; Yijun Yang; Raju Thomas; Manish Ranjan; Debasis Mondal; Krzysztof Moroz; Zhide Fang; Bashir M Rezk; Krishnarao Moparty; Suresh C Sikka; Oliver Sartor; Asim B Abdel-Mageed
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

Review 8.  BMPs and their clinical potentials.

Authors:  Meejung Kim; Senyon Choe
Journal:  BMB Rep       Date:  2011-10       Impact factor: 4.778

Review 9.  Bone morphogenetic protein signaling in musculoskeletal cancer.

Authors:  Myrto Bami; Andreas F Mavrogenis; Andrea Angelini; Mandy Milonaki; Evanthia Mitsiokapa; Dimitrios Stamoulis; Panayotis N Soucacos
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-04       Impact factor: 4.553

10.  Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology.

Authors:  Brian W C Tse; Kieran F Scott; Pamela J Russell
Journal:  Prostate Cancer       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.